These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 25319228

  • 1. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
    Heger-Mahn D, Pabst G, Dienel A, Schläfke S, Klipping C.
    Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
    [Abstract] [Full Text] [Related]

  • 2. Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
    Friedrich C, Port A, Ring A, Graefe-Mody U, Giessmann T, Iovino M, Woerle HJ.
    Clin Drug Investig; 2011 Dec; 31(9):643-53. PubMed ID: 21714581
    [Abstract] [Full Text] [Related]

  • 3. Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.
    Macha S, Mattheus M, Pinnetti S, Woerle HJ, Broedl UC.
    Clin Drug Investig; 2013 May; 33(5):351-7. PubMed ID: 23512637
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W, al-Yacoub G, Fuhrmeister A.
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [Abstract] [Full Text] [Related]

  • 6. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Nov; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole does not affect the bioavailability of oral contraceptives.
    Fuchs W, Sennewald R, Klotz U.
    Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
    Trezza C, Ford SL, Gould E, Lou Y, Huang C, Ritter JM, Buchanan AM, Spreen W, Patel P.
    Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study.
    Taekema-Roelvink ME, Swart PJ, Kuipers ME, Krauwinkel WJ, Visser N, Smulders RA.
    Clin Ther; 2005 Sep; 27(9):1403-10. PubMed ID: 16291413
    [Abstract] [Full Text] [Related]

  • 10. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 11. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE, Mesure R.
    Br J Clin Pharmacol; 1995 Nov; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [Abstract] [Full Text] [Related]

  • 12. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
    Kelly S, Davies E, Fearns S, McKinnon C, Carter R, Gerlinger C, Smithers A.
    Clin Drug Investig; 2010 Nov; 30(5):325-36. PubMed ID: 20384388
    [Abstract] [Full Text] [Related]

  • 13. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U, Jung-Hoffmann C, Kuhl H.
    Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
    [Abstract] [Full Text] [Related]

  • 14. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W, Mellinger U, Parke S, Serrani M.
    Clin Drug Investig; 2011 Aug; 31(8):573-584. PubMed ID: 21721593
    [Abstract] [Full Text] [Related]

  • 15. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [Abstract] [Full Text] [Related]

  • 16. Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
    Sabo JP, Lang B, Elgadi M, Huang F.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):514-9. PubMed ID: 25385099
    [Abstract] [Full Text] [Related]

  • 17. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 18. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
    Olsson B, Landgren BM.
    Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
    [Abstract] [Full Text] [Related]

  • 19. Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
    Gersten J, Hsieh J, Weiss H, Ricciotti NA.
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):635-642. PubMed ID: 27287084
    [Abstract] [Full Text] [Related]

  • 20. Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.
    Ankrom W, Xu J, Vallee MH, Dockendorf MF, Armas D, Boinpally R, Min KC.
    J Clin Pharmacol; 2020 Sep; 60(9):1157-1165. PubMed ID: 32297990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.